These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
583 related articles for article (PubMed ID: 25935115)
1. Computational Analysis of CRTh2 receptor antagonist: A Ligand-based CoMFA and CoMSIA approach. Babu S; Sohn H; Madhavan T Comput Biol Chem; 2015 Jun; 56():109-21. PubMed ID: 25935115 [TBL] [Abstract][Full Text] [Related]
2. Docking-based CoMFA and CoMSIA studies on naphthyl-substituted diarylpyrimidines as NNRTIs. Wu HQ; Yao J; He QQ; Chen FE SAR QSAR Environ Res; 2014; 25(10):761-75. PubMed ID: 25242254 [TBL] [Abstract][Full Text] [Related]
3. Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA) studies on α(1A)-adrenergic receptor antagonists based on pharmacophore molecular alignment. Zhao X; Chen M; Huang B; Ji H; Yuan M Int J Mol Sci; 2011; 12(10):7022-37. PubMed ID: 22072933 [TBL] [Abstract][Full Text] [Related]
4. 3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors. Patel PD; Patel MR; Kaushik-Basu N; Talele TT J Chem Inf Model; 2008 Jan; 48(1):42-55. PubMed ID: 18076152 [TBL] [Abstract][Full Text] [Related]
5. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models. Bhongade BA; Gadad AK J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035 [TBL] [Abstract][Full Text] [Related]
6. 3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA. Doddareddy MR; Jung HK; Cha JH; Cho YS; Koh HY; Chang MH; Pae AN Bioorg Med Chem; 2004 Apr; 12(7):1613-21. PubMed ID: 15028254 [TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR analysis of human immunodeficiency virus entry-1 inhibitors by CoMFA and CoMSIA. Pirhadi S; Ghasemi JB Eur J Med Chem; 2010 Nov; 45(11):4897-903. PubMed ID: 20810190 [TBL] [Abstract][Full Text] [Related]
8. Insight into the structural requirements of proton pump inhibitors based on CoMFA and CoMSIA studies. Nayana MR; Sekhar YN; Nandyala H; Muttineni R; Bairy SK; Singh K; Mahmood SK J Mol Graph Model; 2008 Oct; 27(3):233-43. PubMed ID: 18676164 [TBL] [Abstract][Full Text] [Related]
9. 3D QSAR pharmacophore, CoMFA and CoMSIA based design and docking studies on phenyl alkyl ketones as inhibitors of phosphodiesterase 4. Gaurav A; Singh R Med Chem; 2012 Sep; 8(5):894-912. PubMed ID: 22741782 [TBL] [Abstract][Full Text] [Related]
10. Molecular Modeling Study on Diazine Indole Acetic Acid Derivatives for CRTH2 Inhibitory Activity. Babu S; Rupa M; Nagarajan SK; Sohn H; Madhavan T Comb Chem High Throughput Screen; 2016; 19(6):444-60. PubMed ID: 27137916 [TBL] [Abstract][Full Text] [Related]
11. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods. Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818 [TBL] [Abstract][Full Text] [Related]
12. Structure based 3D-QSAR studies of Interleukin-2 inhibitors: Comparing the quality and predictivity of 3D-QSAR models obtained from different alignment methods and charge calculations. Halim SA; Zaheer-ul-Haq Chem Biol Interact; 2015 Aug; 238():9-24. PubMed ID: 26051521 [TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR Studies on Barbituric Acid Derivatives as Urease Inhibitors and the Effect of Charges on the Quality of a Model. Ul-Haq Z; Ashraf S; Al-Majid AM; Barakat A Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27144563 [TBL] [Abstract][Full Text] [Related]
14. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor. Zhang H; Li H; Ma Q J Mol Graph Model; 2007 Jul; 26(1):226-35. PubMed ID: 17208024 [TBL] [Abstract][Full Text] [Related]
15. Pharmacophore modeling, virtual screening and 3D-QSAR studies of 5-tetrahydroquinolinylidine aminoguanidine derivatives as sodium hydrogen exchanger inhibitors. Bhatt HG; Patel PK Bioorg Med Chem Lett; 2012 Jun; 22(11):3758-65. PubMed ID: 22546667 [TBL] [Abstract][Full Text] [Related]
16. Design of novel quinazolinone derivatives as inhibitors for 5HT7 receptor. Chitta A; Jatavath MB; Fatima S; Manga V J Recept Signal Transduct Res; 2012 Feb; 32(1):3-16. PubMed ID: 22171569 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, pharmacological evaluation and in silico ADMET prediction of novel substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonists based on predictive 3D QSAR models. Vyas VK; Gupta N; Ghate M; Patel S SAR QSAR Environ Res; 2014; 25(2):117-46. PubMed ID: 24598006 [TBL] [Abstract][Full Text] [Related]
18. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators. Gajjar KA; Gajjar AK Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214 [TBL] [Abstract][Full Text] [Related]
19. 3D QSAR studies on substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonist. Vyas VK; Ghate M; Chintha C; Patel P Curr Comput Aided Drug Des; 2013 Sep; 9(3):433-45. PubMed ID: 24010938 [TBL] [Abstract][Full Text] [Related]
20. Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of some benzimidazole derivatives with trichomonicidal activity. Pérez-Villanueva J; Medina-Franco JL; Caulfield TR; Hernández-Campos A; Hernández-Luis F; Yépez-Mulia L; Castillo R Eur J Med Chem; 2011 Aug; 46(8):3499-508. PubMed ID: 21621311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]